O’Melveny’s New York Office Recognized for ‘Sterling Life Sciences Litigation’ Practice by IAM’s Patent 1000June 01, 2016 FOR IMMEDIATE RELEASE
NEW YORK, NY--JUNE 1, 2016--Intellectual Asset Management’s (IAM) annual Patent 1000 Guide 2016 has highly ranked O’Melveny’s New York Life Sciences Litigation Practice.
The Guide also highlighted the addition of Lisa Pensabene to the practice in 2014, saying that she “supercharge(d) its pharmaceutical and biotechnology practice” and is a “a true pleasure to deal with.” The Guide quoted Pensabene’s clients, who “call her ‘smart and strategic,’ and praise her ability to ‘master very complex science and explain it to a lay audience.’”
O’Melveny’s clients shape markets, set precedents, and break boundaries. They are stalwarts and innovators, the names you trust and the next big thing. And for more than a century, O’Melveny has been right beside them, kicking down walls and putting up defenses to help our clients achieve their most important goals. With approximately 700 lawyers in 15 offices worldwide guided by the principles of excellence, leadership, and citizenship, we uphold a tradition of treating our clients’ challenges and opportunities as our own. What do you want to achieve? For the answers, please visit www.omm.com.
O'Melveny & Myers